CDKN2A and neoplasm: RASSF1A inactivation may alter the cell cycle in both tumor types, whereas hypermethylation of CDKN2A and inhibition of CDKN1B and CDKN2C caused by MEN1 loss are characteristic of PanNETs (141, 204, 205).